background
sinc
discoveri
middl
east
respiratori
syndrom
coronaviru
merscov
diagnost
protocol
quickli
publish
deploy
global
object
set
assess
qualiti
merscov
molecular
diagnost
worldwid
studi
design
sensit
specif
assess
use
sampl
contain
differ
viral
load
merscov
common
coronavirus
result
panel
sent
particip
laboratori
contin
return
panel
resultsscor
rang
laboratori
laboratori
respond
report
quantit
result
semiquantit
ctvalu
time
posit
report
qualit
result
major
specif
techniqu
use
realtim
rtpcr
use
recommend
target
upe
evalu
confirm
rtpcr
target
less
sensit
therefor
advis
primari
diagnost
conclus
first
extern
qualiti
assess
merscov
panel
give
good
insight
molecular
diagnost
techniqu
perform
sensit
specif
detect
merscov
rna
global
overal
laboratori
capabl
detect
merscov
differ
sensit
observ
laboratori
report
fals
merscov
posit
singl
assay
result
show
room
improv
import
use
confirmatori
target
novel
betacoronaviru
name
middl
east
respiratori
syndrom
coronaviru
merscov
identifi
caus
sever
respiratori
diseas
human
middl
east
within
week
initi
report
protocol
publish
diagnos
agent
realtim
revers
transcriptas
polymeras
chain
reaction
rtpcr
first
report
realtim
rtpcr
assay
describ
two
target
one
locat
upstream
envelop
gene
upe
one
within
open
read
frame
second
report
includ
diagnost
screen
algorithm
describ
assay
target
gene
sensit
assay
therefor
recommend
confirmatori
assay
rather
rtpcr
meantim
laboratori
develop
assay
target
nucleocapsid
n
gene
show
similar
sensit
upe
rtpcr
world
health
organ
recent
publish
updat
interim
recommend
laboratori
test
merscov
upe
rtpcr
recommend
firstlin
screen
assay
accord
recommend
posit
merscov
rtpcr
subsequ
confirm
either
n
gene
rtpcr
altern
confirmatori
rtpcr
sequenc
n
gene
rna
depend
rna
polymeras
rdrp
gene
describ
present
laboratori
around
world
implement
inhous
commerci
method
merscov
molecular
diagnost
mostli
base
describ
public
substanti
divers
nucleic
acid
extract
method
rtpcr
master
mix
thermocycl
use
extern
qualiti
assess
eqa
studi
give
insight
possibl
effect
variat
assay
perform
therebi
allow
particip
laboratori
assess
qualiti
current
diagnosi
identifi
possibl
weak
strength
rang
diagnost
method
use
first
merscov
eqa
panel
set
assess
qualiti
nucleic
assay
test
nat
assay
merscov
worldwid
inform
particip
merscov
pcr
eqa
sent
member
european
network
import
viral
diseas
enivd
extern
collabor
partner
european
nation
microbiolog
focal
point
nmfp
diagnost
laboratori
charg
merscov
diagnost
suggest
eqa
request
ecdc
part
joint
initi
offic
europ
support
laboratori
prepared
build
across
eueea
european
region
member
state
total
particip
invit
take
part
merscov
eqa
studi
particip
studi
free
charg
benchmark
particip
receiv
complet
anonym
list
submit
result
laboratori
recogniz
particip
agre
public
anonym
result
merscov
strain
emc
provid
erasmu
mc
rotterdam
netherland
human
coronavirus
hcov
cultiv
robert
kochinstitut
berlin
germani
virus
grown
vero
cell
cell
cultur
supernat
harvest
inactiv
heat
h
c
gamma
irradi
kilo
gray
profici
test
panel
includ
seven
sampl
contain
serial
dilut
merscov
posit
cell
cultur
supernat
four
sampl
common
human
coronaviru
posit
cultur
supernat
two
neg
control
sera
specif
control
sampl
freezedri
lyophil
reagent
op
diagnost
nj
usa
use
epsilon
pilot
freez
dryer
martin
christ
gmbh
osterod
harz
germani
ml
glass
vial
human
coronaviru
propag
previous
describ
infecti
viru
detect
test
residu
infect
heat
gamma
irradi
inocul
cell
cultur
particip
assur
provid
nonbiohazard
materi
recommend
handl
materi
care
recommend
human
specimen
gener
panel
valid
robert
kochinstitut
rki
three
refer
laboratori
univers
bonn
medic
centr
germani
erasmu
mc
rotterdam
netherland
univ
siti
vienna
austria
use
inhous
valid
method
well
commerci
assay
sampl
reconstitut
l
water
analyz
accord
local
use
rtpcr
protocol
eqa
sampl
ship
regular
mail
courier
instruct
use
evalu
form
log
result
includ
inform
assay
protocol
interpret
result
diagnosi
sampl
coronaviru
strain
identifi
number
genom
copi
possibl
well
problem
encount
base
valid
return
laboratori
result
sampl
omit
analysi
eqa
panel
sinc
concentr
sampl
low
equal
distribut
return
quantit
result
recalcul
copiesml
uniform
copiesl
multipli
factor
measur
perform
lab
point
per
correct
result
per
sampl
reward
thu
point
would
result
score
furthermor
test
differ
perform
pcr
target
n
dataset
see
tabl
student
ttest
ftest
varianc
calcul
microsoft
excel
respons
rate
particip
request
merscov
eqa
panel
laboratori
see
supplementari
tabl
major
laboratori
submit
separ
result
multipl
rtpcr
assay
reflect
confirmatori
diagnost
algorithm
result
panel
result
laboratori
indic
use
confirmatori
pcr
report
one
final
result
fig
show
geograph
locat
particip
come
countri
particip
locat
european
union
eu
member
countri
asia
western
asia
middl
east
africa
noneu
european
countri
latin
america
north
america
oceania
accord
unit
nation
geograph
area
total
panel
result
return
n
report
quantit
result
copiesl
copiesml
qrtpcr
n
report
semiquantit
result
cycl
threshold
ct
valu
realtim
rtpcr
timetoposit
case
revers
transcriptas
recombinas
polymeras
amplif
rtrpa
assay
n
report
qualit
result
posit
neg
total
genom
target
use
among
differ
target
realtim
rtpcr
rtrpa
n
assay
target
sequenc
n
gene
rdrp
may
indic
number
unpublish
inhous
develop
test
use
tabl
summar
number
panel
result
return
genom
target
combin
analysi
type
quantit
semiquantit
qualit
recommend
upe
wide
use
rtpcr
follow
overal
data
show
perform
major
laboratori
good
return
result
score
point
score
furthermor
lab
return
panel
score
lab
score
lab
score
one
lab
score
tabl
show
percentag
correct
result
per
merscov
posit
sampl
total
eqa
panel
n
result
per
assay
type
includ
median
rang
per
sampl
quantit
semiquantit
result
quantit
result
show
quit
big
varianc
viral
load
vl
lowest
varianc
sampl
log
genom
equival
geqml
highest
sampl
log
geqml
without
sampl
taken
account
differ
observ
despit
fact
laboratori
indic
use
quantifi
vitro
transcrib
rna
provid
european
viru
archiv
eva
quantifi
standard
studi
varianc
due
quantif
transform
ct
valu
geqml
varianc
report
realtim
rtpcr
result
ct
valu
viral
load
varianc
quantit
result
describ
recalcul
geqml
ctvalu
arbitrari
effici
equal
ct
variat
compar
semiquantit
data
eqa
panel
ct
sampl
respect
wide
rang
report
load
therefor
attribut
quantif
transform
furthermor
assess
differ
yield
specif
target
return
panel
result
avail
tabl
advic
best
target
use
base
ctvalu
distribut
ct
valu
semiquantit
rtpcr
target
upe
compar
use
student
ttest
check
varianc
similar
use
ftest
tabl
ct
valu
produc
rtpcr
significantli
higher
target
comparison
wherea
signific
differ
observ
four
target
assess
specif
merscov
molecular
diagnost
two
neg
control
sampl
four
known
common
human
coronavirus
name
sampl
sampl
sampl
sampl
part
first
merscov
eqa
panel
betacoronavirus
similar
merscov
two
laboratori
report
merscov
rna
detect
one
neg
control
addit
laboratori
report
detect
merscov
rna
sampl
spike
nonmer
hcov
three
sampl
one
laboratori
sampl
alon
howev
one
laboratori
report
merscov
rna
detect
sampl
one
laboratori
sampl
contain
fals
posit
result
associ
specif
assay
laboratori
use
protocol
report
reactiv
may
suggest
aspecif
result
origin
contamin
rather
nonspecif
reaction
nonmer
hcov
differ
interpret
algorithm
raw
data
nevertheless
total
laboratori
report
falseposit
result
laboratori
miss
one
common
hcov
one
laboratori
report
perform
molecular
diagnost
nonmer
cov
well
abl
detect
common
human
coronavirus
sinc
discoveri
merscov
diagnost
protocol
quickli
deploy
global
studi
particip
return
multipl
result
first
merscov
eqa
assess
good
overal
result
quarter
laboratori
report
quantit
result
though
varianc
report
viral
concentr
high
may
due
fact
intern
nat
standard
avail
use
inactiv
complet
viru
control
provid
rki
recommend
sinc
take
variat
nucleic
acid
extract
well
rtpcr
variat
account
howev
use
quantifi
rna
control
provid
european
viral
archiv
eva
mere
quantifi
amount
rna
ad
rtpcr
take
variat
induc
nucleic
acid
extract
account
though
differ
perform
rtpcr
mix
measur
use
rna
control
known
variat
viral
load
quantifi
inhous
standard
much
higher
laboratori
worldwid
use
one
nat
handl
exact
way
clinic
sampl
qcmd
cmv
panel
unpublish
result
merscov
eqa
panel
almost
report
result
obtain
inhous
realtim
rtpcr
assay
publish
corman
et
al
corman
et
al
lu
x
et
al
mostli
use
one
laboratori
report
use
unpublish
assay
target
score
indic
well
valid
inhous
assay
minor
laboratori
use
techniqu
realtim
rtpcr
like
rtrpa
convent
rtpcr
merscov
detect
recommend
use
confirmatori
rtpcr
second
merscov
genom
target
follow
major
laboratori
though
multipl
laboratori
indic
sequenc
avail
confirm
current
number
merscov
specif
commerci
realtim
rtpcr
assay
market
advantag
includ
intern
posit
control
singl
kit
whose
qualiti
regul
author
report
commerci
realtim
rtpcr
n
use
fast
track
diagnost
lab
score
genesig
primer
design
lab
score
real
star
merscov
altona
lab
score
furthermor
investig
differ
ct
level
publish
target
taken
report
panel
result
account
found
ct
valu
produc
rtpcr
significantli
higher
target
comparison
wherea
signific
differ
observ
four
target
combin
lower
number
correct
result
observ
data
shown
indic
weakest
rtpcr
target
publish
rtpcr
suggest
public
corman
et
al
composit
merscov
eqa
panel
complet
reflect
real
life
perform
test
clinic
sampl
mere
give
indic
analyt
sensit
specif
molecular
diagnost
test
use
interpret
result
one
need
realiz
viral
concentr
merscov
infect
patient
throat
swab
serum
faec
may
lower
rang
depend
time
sampl
merscov
detect
upper
respiratori
tract
sampl
nose
swab
infect
human
suggest
potenti
miss
case
specimen
collect
lower
respiratori
tract
sampl
trachea
aspir
bronchoalveolar
lavag
merscov
concentr
found
significantli
higher
upper
middl
respiratori
tract
sampl
though
sampl
may
easi
take
patient
respiratori
distress
taken
fact
diagnost
sampl
sent
merscov
molecular
diagnost
throat
swab
contain
low
merscov
rna
concentr
report
result
correct
sampl
lowest
concentr
panel
median
viral
load
geqml
may
reflect
underdiagnosi
merscov
infect
due
sensit
problem
diagnost
method
use
small
portion
laboratori
first
extern
qualiti
assess
merscov
panel
give
good
insight
molecular
diagnost
techniqu
perform
sensit
specif
detect
merscov
rna
global
overal
score
good
though
sensit
detect
clinic
sampl
laboratori
advis
valid
anoth
confirmatori
target
critic
evalu
result
survey
indic
robust
capabl
capac
detect
confirm
merscov
particip
laboratori
june
find
laboratori
produc
fals
posit
result
disturb
support
confirmatori
test
either
second
rtpcr
target
andor
second
laboratori
